Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Mar
2
2021
IPR and CBM Statistics for Final Written Decisions Issued in October and November 2020 Finnegan
Mar
10
2021
IPR and CBM Statistics for Final Written Decisions Issued in December 2020 and January 2021 Finnegan
Apr
6
2021
Federal Circuit: Mandamus Petitions Challenging Institution Denial Are Unlikely to Show Right to Relief Finnegan
Apr
20
2021
No Standing on Appeal from PTAB Where Appellant Cannot Prove Injury in Fact Finnegan
May
24
2021
Particularity in Petitions Produces Positive Post-Grant Review Proceedings Finnegan
Jun
16
2021
Patent Underlying Walker Process Claim is Not Enough to Give Rise to Federal Circuit Jurisdiction Finnegan
Jul
1
2021
Ready, Set, Go: Crystalize Your Thinking Finnegan
Jul
30
2021
Coffee “or” Tea? Is That Coffee or Tea, but Not Both? Or Possibly Both? Finnegan
Aug
5
2021
“Shall Be” Language May Not Effectuate a Present Automatic Assignment of Rights Finnegan
Aug
27
2021
Pay the (PTO) Piper: Correct Erroneously Underpaid Maintenance Fees to Avoid Inequitable Conduct Challenges Finnegan
Sep
17
2021
None of Us Saw Them Stop the PTA Giveaway Finnegan
Feb
14
2022
Strategically Filed Request for Rehearing Leads PTAB to Institute IPR Finnegan
Mar
2
2021
Pun Intended, but Not Infringing: 9th Circuit Finds LETTUCE TURNIP THE BEET Aesthetically Functional Finnegan
Apr
15
2021
Not So Sweet: Indicia of Nonobviousness Could Not Save Claims Directed to Sweetened Beverage Brewing Devices Finnegan
Apr
20
2021
Be Careful Claiming Trees in the Middle of the Forest—and Be Sure You Win on a Dispositive Issue Finnegan
May
7
2021
IPR and CBM Statistics for Final Written Decisions Issued in February and March 2021 Finnegan
Jun
21
2021
Supreme Court Requires USPTO Director Discretion to Review PTAB Decisions Finnegan
Jul
2
2021
Double Patenting Is Grounds for Refusal Against European Patent Applications Says EPO in G4/19 Finnegan
Jul
14
2021
Prosecution Pointer 285 Finnegan
Aug
5
2021
E-Cigarette Respondent’s Reverse Domain Name Hijacking Argument Goes Up In Smoke Finnegan
Aug
24
2021
The Creative POSITA Finnegan
Sep
7
2021
PTAB Challenges to Orange Book-Listed and Biologic Patents Finnegan
Sep
10
2021
Augmented Reality/Virtual Reality Patent Prosecution Update: 2021 Q1 Prosecution Statistics Finnegan
Oct
28
2021
Second Circuit Gives Halloween Treat to Friday the 13th Screenwriter Finnegan
Nov
3
2021
Whiskey’s Good Proofing Water, But It Doesn’t Tell You Who the Real Peaky Blinders Are Finnegan
Jan
18
2022
“Show More of You”: Amgen v. Sandoz, Battling it Out on Amgen’s Otezla® Drug Finnegan
Feb
10
2022
Payment Confirmation Establishes Filing Date in IPR Petitions Finnegan
Feb
15
2022
Petitioner Estopped Due to Final Written Decisions in Parallel IPR Proceedings with Petitions Filed Simultaneously Finnegan
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins